Loading…
Lobbying Spend
—
Filings
4
Firms Hired
1
Active Period
2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Stem Cell Therapeutic and Research Reauthorization Act of 2025
2026 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (H.R. 5160/S. 4109).
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2026
2026 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (H.R. 5160/S. 4109).
Client expense: — · Firm income: $20,000
Matched citations: S. 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2025
2026 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (HR5160/S4109).
Client expense: — · Firm income: $90,000
Matched citations: HR5160
Stem Cell Therapeutic and Research Reauthorization Act of 2026
2026 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (HR5160/S4109).
Client expense: — · Firm income: $90,000
Matched citations: S4109
Source: Senate LDA